The humanoid robot lifts 65 lbs in lab test, showcasing whole-body control, actuator strength, and stable, repeatable ...

The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive ...

The rapid rise of weight-loss injections is reshaping the quantity of food people eat — leaving farmers in some areas with a growing surplus of unsold potatoes. The trend toward healthier eating ...

Automating repetitive tasks in Excel can significantly enhance efficiency and Office Scripts provide a structured way to achieve this. By incorporating loops, you can create workflows that dynamically ...

Editor's Note: Eight juveniles were arrested and 24 were issued curfew violation citations associated with the gathering. Our latest story can be found here. Our original story continues below. A ...

Retatrutide, an experimental diabetes drug produced by Eli Lilly, helped some trial participants lose over 15% of their body weight, according to results of a new study released by the drug ...

Those driving on the Far Northside of San Antonio will soon heed a new traffic pattern. The Texas Department of Transportation (TxDOT) announced that a major shift will be implemented in the area next ...

Fans pleaded with Oprah Winfrey to go easy on GLP-1's after the media titan showed up at Paris Fashion Week looking so trim she was "unrecognizable," RadarOnline.com can reveal. As the video went ...

The Marine Corps has dropped its long-standing height-and-weight screening process. MARADMIN 066/26, released Feb. 26, 2026, finalizes the switch to waist-to-height ratio (WHtR) as the primary ...

Six Flags Over Texas will debut Tormenta Rampaging Run, featuring a 179-foot loop and 87 mph speeds. Kristine Hansen is a design, food and drink, and travel writer based in Milwaukee, Wisconsin. She ...

Novo Nordisk and its Chinese partner have reported up to 19.7% weight loss in patients who took their triple agonist for 24 weeks, illuminating a potential path forward for the Danish drugmaker as it ...

Novo's drug, CagriSema, didn't achieve its key goal of demonstrating non-inferiority on weight loss when compared to Eli Lilly's rival drug tirzepatide. The stock plummeted on Monday, hitting its ...